BCL6 enables leukemia cells to cope with inhibition of oncogenic tyrosine kinases

ChEBI2011-02-15 更新2026-07-21 收录

白血病耐药机制

BCL6基因

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-24426 数据链接链接失效反馈

官方服务：

资源简介：

BCL6 enables leukemia cells to cope with inhibition of oncogenic tyrosine kinases

创建时间：

2011-02-15

Transcriptome-wide analysis of RNA N6-methyladenosine in Adriamycin-resistant acute myeloid leukemia cells

白血病耐药机制

RNAm6A修饰分析

N6-Methyladenosine (m6A) is the most abundant post-transcriptional modification in eukaryotes, the imbalance of which is reported to be associated with various pathological processes, including drug r

NIAID Data Ecosystem60

Individual multidrug resistance patterns in AML patients point to the need for personalized molecular analysis

白血病耐药机制

分子诊断

In this unique study, based on paired samples obtained at AML diagnosis and at relapse, we assessed 380 multidrug-resistance-related genes, using TaqMan-based qRT-PCR, as indicated by reports publishe

NIAID Data Ecosystem40

Mapping the glucocorticoid gene regulatory network and alterations that contribute to steroid resistance in childhood acute lymphoblastic leukemia [Hi-ChIP]. Mapping the glucocorticoid gene regulatory network and alterations that contribute to steroid resistance in childhood acute lymphoblastic leukemia [Hi-ChIP]

白血病耐药机制

基因调控网络

Glucocorticoids (GCs) are a mainstay of contemporary, multi-drug chemotherapy in the treatment of acute lymphoblastic leukemia (ALL). Although overall survival rates of childhood ALL have improved, re

NIAID Data Ecosystem30

Supplementary Table S1 from Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia

白血病耐药机制

线粒体自噬功能筛选

Supplementary Table 1 shows the results of our CRISPRi screens.

Figshare2023-07-07 更新60

DDX6 undergoes phase separation to modulate metabolic plasticity and drug resistance in AML [CRISPR Screen]

白血病耐药机制

CRISPRi筛选

Chemoresistance in acute myeloid leukemia (AML) is a major cause of poor prognosis and frequent relapse among patients. Under stress conditions such as chemotherapy or radiotherapy, processing bodies

NIAID Data Ecosystem30

BCL6 enables leukemia cells to cope with inhibition of oncogenic tyrosine kinases

资源简介：

相关数据集